Latest news
Press Release Service: Adicet Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates - CRISPR Medicine NewsCRISPR Medicine News · Fri, 07 Aug 2026 05:50:43 GMTKindred Companion Sciences Unveils First Dogs Genetically Edited to Remove the Major Dog Allergen - CRISPR Medicine NewsCRISPR Medicine News · Wed, 05 Aug 2026 23:10:23 GMTADICET Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 22:49:43 GMTAdicet Bio (NASDAQ:ACET) Posts Earnings Results, Misses Estimates By $0.30 EPS - MarketBeatMarketBeat · Wed, 05 Aug 2026 21:23:41 GMTAdicet Bio reports Q2 EPS ($1.99), consensus ($1.64) - TipRanksTipRanks · Wed, 05 Aug 2026 21:07:05 GMTMore Than Two Decades at Johnson & Johnson: Lipocine's New Director - Stock TitanStock Titan · Mon, 03 Aug 2026 12:00:00 GMTAdicet Bio Inc Actuals & Estimates (NASDAQ:ACET) - TradingViewTradingView · Sat, 01 Aug 2026 05:41:36 GMT